Ensign Peak Advisors’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,408,852
Closed -$3.56M 1732
2024
Q3
$3.56M Buy
1,408,852
+574,598
+69% +$1.87M 0.01% 743
2024
Q2
$3.56M Hold
834,254
0.01% 718
2024
Q1
$6.17M Buy
+834,254
New +$7.02M 0.01% 570

Other funds holding GUTS

Ensign Peak Advisors's GUTS Position: Q4 2024 in Review

Ensign Peak Advisors sold out of Fractyl Health (GUTS) in Q4 2024, closing a stake of 1,408,852 shares — an estimated $3.56M sold.

Ensign Peak Advisors first reported a position in GUTS in Q1 2024 and held it in 3 quarters. The position peaked at $6.17M in Q1 2024. 65 funds tracked by Wall St. Rank hold GUTS as of Q4 2024.

  • Ensign Peak Advisors reported no remaining Fractyl Health position as of Q4 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 1,408,852 Fractyl Health shares in Q4 2024, an estimated $3.56M.
  • Ensign Peak Advisors first reported a position in Fractyl Health in Q1 2024 and held it in 3 quarters.
  • Ensign Peak Advisors's Fractyl Health position peaked at $6.17M in Q1 2024.
  • 65 funds tracked by Wall St. Rank held Fractyl Health as of Q4 2024.

Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.